survival - Time to event analysis - median (IQR) is <75% experience event - Cross Validated
Overall survival of patients with metastatic breast cancer in Sweden: a nationwide study | British Journal of Cancer
Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer
Novartis announces NEJM publication of updated analysis from ELIANA trial showing longer-term durable remissions with Kymriah(TM) in children, young adults with r/r ALL
Interpreting Survival Probability in Relation to 'Number at Risk' and Median Follow-Up Times - interpret - Datamethods Discussion Forum
a Kaplan?Meier relapse-free survival (median follow-up time 42 months)... | Download Scientific Diagram
TIBSOVO® (ivosidenib tablets) an IDH1 Inhibitor
Efficacy of KISQALI® (ribociclib) + AI in 1L Postmenopausal | HCP
Survival curves. (A) Overall survival (median 18.2 months). (B) PS of... | Download Scientific Diagram
Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94) | Radiation Oncology | Full Text
Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2− metastatic breast cancer: an observational study of the SONABRE Registry - The Lancet Regional Health – Europe
GraphPad Prism 10 Statistics Guide - Determining the median followup time
Survival Analysis
primed.info
Survival Analysis in R
a Kaplan–Meier survival curve with a median follow-up time of... | Download Scientific Diagram
Overall survival for suPAR levels above or below a 12 ng/mL cutoff.... | Download Scientific Diagram
Median Survival Time - an overview | ScienceDirect Topics
Let's Flip: An Approach to Understand Median Follow-up by the Reverse Kaplan-Meier Estimator from a Statistical Programmer's
Survival Analysis in R
A retrospective analysis of changes in distant and breast cancer related disease-free survival events in adjuvant breast cancer trials over time | Scientific Reports
The overall survival did not reach median. The median progression free... | Download Scientific Diagram
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer | NEJM
Survival Analysis
Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors | Scientific Reports
